These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 11839569)
1. Cytokeratins as targets for bile acid-induced toxicity. Fickert P; Trauner M; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H Am J Pathol; 2002 Feb; 160(2):491-9. PubMed ID: 11839569 [TBL] [Abstract][Full Text] [Related]
2. Bile acid-induced Mallory body formation in drug-primed mouse liver. Fickert P; Trauner M; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H Am J Pathol; 2002 Dec; 161(6):2019-26. PubMed ID: 12466118 [TBL] [Abstract][Full Text] [Related]
3. The role of the hepatocyte cytokeratin network in bile formation and resistance to bile acid challenge and cholestasis in mice. Fickert P; Fuchsbichler A; Wagner M; Silbert D; Zatloukal K; Denk H; Trauner M Hepatology; 2009 Sep; 50(3):893-9. PubMed ID: 19585611 [TBL] [Abstract][Full Text] [Related]
4. Mallory body formation in primary biliary cirrhosis is associated with increased amounts and abnormal phosphorylation and ubiquitination of cytokeratins. Fickert P; Trauner M; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H J Hepatol; 2003 Apr; 38(4):387-94. PubMed ID: 12663227 [TBL] [Abstract][Full Text] [Related]
5. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Pojer C; Zenz R; Lammert F; Stieger B; Meier PJ; Zatloukal K; Denk H; Trauner M Gastroenterology; 2001 Jul; 121(1):170-83. PubMed ID: 11438506 [TBL] [Abstract][Full Text] [Related]
6. Pathologic changes in the cytokeratin pericanalicular sheath in experimental cholestasis and alcoholic fatty liver. Ohta M; Marceau N; French SW Lab Invest; 1988 Jul; 59(1):60-74. PubMed ID: 2455832 [TBL] [Abstract][Full Text] [Related]
7. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice. Cadrin M; Anderson NM; Aasheim LH; Kawahara H; Franks DJ; French SW Lab Invest; 1995 Apr; 72(4):453-60. PubMed ID: 7536860 [TBL] [Abstract][Full Text] [Related]
8. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation. Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718 [TBL] [Abstract][Full Text] [Related]
9. Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice. Zollner G; Fickert P; Silbert D; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H; Trauner M Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G184-91. PubMed ID: 11751172 [TBL] [Abstract][Full Text] [Related]
10. Oncosis represents the main type of cell death in mouse models of cholestasis. Fickert P; Trauner M; Fuchsbichler A; Zollner G; Wagner M; Marschall HU; Zatloukal K; Denk H J Hepatol; 2005 Mar; 42(3):378-85. PubMed ID: 15710221 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of intermediate filaments in the process of developing hepatic steatosis. Park JE; Kim HT; Lee S; Lee YS; Choi UK; Kang JH; Choi SY; Kang TC; Choi MS; Kwon OS Proteomics; 2011 Jul; 11(14):2777-89. PubMed ID: 21674798 [TBL] [Abstract][Full Text] [Related]
12. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats. Purucker E; Marschall HU; Winograd R; Matern S Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121 [TBL] [Abstract][Full Text] [Related]
13. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys. Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236 [TBL] [Abstract][Full Text] [Related]
14. Excretory function in cultured hepatocytes from griseofulvin-treated mice. Kawahara H; Marceau N; French SW Lab Invest; 1989 Dec; 61(6):609-22. PubMed ID: 2481150 [TBL] [Abstract][Full Text] [Related]
15. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver. Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414 [TBL] [Abstract][Full Text] [Related]
16. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate. Rost D; Herrmann T; Sauer P; Schmidts HL; Stieger B; Meier PJ; Stremmel W; Stiehl A Hepatology; 2003 Jul; 38(1):187-95. PubMed ID: 12830001 [TBL] [Abstract][Full Text] [Related]
17. Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats. Wang G; Shen H; Rajaraman G; Roberts MS; Gong Y; Jiang P; Burczynski F Eur J Pharmacol; 2007 Mar; 560(1):61-8. PubMed ID: 17292345 [TBL] [Abstract][Full Text] [Related]
18. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis. Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192 [TBL] [Abstract][Full Text] [Related]
19. Biliary secretion and actin-cytokeratin filament distribution in rat hepatocytes during phalloidin-induced cholestasis. Loranger A; Tuchweber B; Youseff I; Marceau N Biochem Cell Biol; 1995; 73(9-10):641-9. PubMed ID: 8714684 [TBL] [Abstract][Full Text] [Related]
20. Ductular reaction at the early terms of common bile duct ligation in the rats. Azmaiparashvili E; Berishvili E; Kakabadze Z; Pilishvili O; Mikautadze E; Solomonia R; Jangavadze M; Kordzaia D Acta Biol Hung; 2012 Sep; 63(3):321-32. PubMed ID: 22963913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]